Subscribe to Newsletter

Genetics and epigenetics

Diagnostics Genetics and epigenetics

New e-book: The value of in-house genomic profiling for precision oncology!

| Sponsored by Thermo Fisher Scientific

Outside the Lab COVID-19

Weathering the Storm

| Michael Schubert

We sit down with Mike Osborn, President of the Royal College of Pathologists, to discuss pandemics, priorities, and the future of pathology

Diagnostics Analytical science

Tracing Plasma DNA Origins

| Liv Gaskill

A new analysis shows potential for determining plasma DNA origins in prenatal testing, organ transplantation, and oncology

Diagnostics Analytical science

The Vast Potential of Single-Cell Analysis

| Zachary Pitluk

Zachary Pitluk outlines the route to single-cell analysis – and the promise it holds for human health and disease

Diagnostics Analytical science

Amplifying Biomarker Signals by Smartphone

| Liv Gaskill

Detecting biomarkers at low concentrations is costly, sometimes inaccessible – could addressable nanoantennae on a smartphone microscope be the answer

Diagnostics Genetics and epigenetics

Let’s Do It Ourselves

| Sponsored by Thermo Fisher Scientific

Healthcare management and patient care both benefit when oncology biomarker testing is performed in-house

Diagnostics Genetics and epigenetics

One Giant Leap for Genomic Diversity

| Michael Schubert

A new study has sequenced 64 haplotypes representing 25 populations – moving human genome reference data closer to reflecting true human diversity

Diagnostics Genetics and epigenetics

A Comprehensive Answer for Cancer

| Sponsored by Thermo Fisher Scientific

Is comprehensive genomic profiling the next step in the evolution of genomics for oncology research and diagnostics?

Diagnostics Biochemistry and molecular biology

Dead Cells Tell Tales

| Liv Gaskill

Using a simple blood test to identify the tissue source and genes of dead cells may be a step forward for noninvasive biopsies

Diagnostics Genetics and epigenetics

127 (Glaucoma) Genes Later

| Liv Gaskill

Findings from the largest genome-wide meta-analysis of primary open-angle glaucoma could lead to new treatment targets

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register